Frankfurt Airport is closing security checkpoints outside the transit area at both terminals on Thursday due to the announced warning strike by security service providers.
GALERIA KAUFHOF
The insolvent department store chain Galeria Karstadt Kaufhof has officially initiated the search for investors.
KSB
felt the effects of the weak economy in the fourth quarter.
MISTER SPEX
benefited from strong growth in its core market of Germany last year. The optician fulfilled the goals he set for himself.
SNP
significantly increased sales and earnings last year. The IT service provider is confident for the current year.
DE BEERS
De Beers Group’s rough diamond sales more than doubled in the first sales cycle of the year compared to the previous one. This was due to solid demand in the USA during the Christmas season and a restart of rough diamond imports to India.
GSK
benefited from strong growth in the best-selling Shingrix vaccine and the new Arexvy vaccine against the RS virus in the final quarter and expects further growth in sales and profits.
HM
gets a new CEO. The Swedish group announced that it has appointed the head of the core brand, Daniel Erver, as CEO and president, effective immediately.
HM
is suffering from declines in sales, delivery problems in the Red Sea and discount campaigns in the current first financial quarter of 2023/24, but has confirmed its margin forecast. The Swedish group wants to keep the dividend for the past financial year at the previous year’s level.
MONDELEZ
US snack company Mondelez’s sales growth slowed in the final quarter of 2023 as consumers held back somewhat in the face of higher prices. For the current year, Mondelez expects lower organic growth than in the previous year.
NOVARTIS
increased its net profit more than fivefold in the final quarter, benefiting from a one-off profit from the spin-off of its Sandoz generics division. Shareholders are to receive a dividend of 3.30 Swiss francs for the full year, 0.10 francs more than in the previous year.
NOVO NORDISK
In view of the enormous demand for the diabetes drug Ozempic and the weight loss drug Wegovy, the net profit surprisingly increased significantly in the final quarter. The Danish pharmaceutical giant expects sales to weaken in 2024.
RAIFFEISEN BANK
earned less last year despite rising net interest income. Higher costs and provisions in the Polish business depressed the result.
ROYAL KPN
increased operating profit and sales in the fourth quarter, exceeding market expectations.
SANTANDER
expects higher profitability for the current year after increasing its profit by more than a fifth in the fourth quarter of 2023 and beating market expectations.
VIVENDI
is now to be divided into four independent listed companies. The board of directors approved the plan for the split, but voted in favor of splitting it into four companies instead of three.
VODAFONE
does not want to join forces with the French Iliad in Italy. The British telecommunications group rejected an improved offer to combine its Italian business with that of Iliad.
===
Contact the author: [email protected]
DJG/ff
(END) Dow Jones Newswires
January 31, 2024 07:29 ET (12:29 GMT)